Abstract
The international society for pharmacoeconomics and outcomes research (ISPOR) defines “Pharmacoeconomics as the field of study that evaluates the behaviour of individuals, firms and markets relevant to the use of pharmaceutical products, services and programs and which frequently focuses on the costs (inputs) and consequences (outcomes) of that use”. It is the description and analysis of the cost of drug therapy to health care systems and society. This prospective observation study was carried out for over a period of 6 months commencing from March 2014 to August 2014 among inpatients of General medicine and Nephrology departments of a tertiary care referral hospital in kerala.All diabetes mellitus patient treated in the Inpatient department of General medicine and Nephrology department during March-August 2014 were monitored, collect relevant data and entered into the data sheet. Based on the inclusion and exclusion criteria of the protocol approved by the IEC, patients belonging to the age group 40-70 of both sex were selected and enrolled for the study.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
